Allurion Technologies, Inc. Restructuring Charges
Allurion Technologies, Inc. (ALUR) reported Restructuring Charges of -$300.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-08-28
- Allurion Technologies, Inc. restructuring charges for the quarter ending 2025-06-30 was -$4.20M.
- Allurion Technologies, Inc. restructuring charges for the quarter ending 2025-03-31 was $3.90M.
- Allurion Technologies, Inc. restructuring charges for the quarter ending 2024-09-30 was $0.00.
- Allurion Technologies, Inc. restructuring charges for fiscal 2024 was $3.90M, a 290.00% increase from fiscal 2023.
- Allurion Technologies, Inc. restructuring charges for fiscal 2023 was $1.00M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 12 month |
|---|---|---|---|
| 2025-06-30 | -$4.20M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-08-19 | -$300.00K 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $3.90M 10-Q/A · filed 2025-08-19 | ||
| 2024-12-31 | $3.90M 10-K/A · filed 2025-08-19 | ||
| 2024-09-30 | $0.00 10-Q/A · filed 2025-08-28 | ||
| 2023-12-31 | $1.00M 10-K/A · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |